These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6134814)

  • 1. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
    Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
    J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and subchronic effects of MJ-13859, a potential antipsychotic drug, on rat brain dopaminergic function.
    McMillen BA
    J Pharmacol Exp Ther; 1985 May; 233(2):369-75. PubMed ID: 2987476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
    Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
    Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
    Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
    [No Abstract]   [Full Text] [Related]  

  • 15. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities.
    Hechler V; Peter P; Gobaille S; Bourguignon JJ; Schmitt M; Ehrhardt JD; Mark J; Maitre M
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1406-14. PubMed ID: 8095552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
    Usuda S; Sano K; Maeno H
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):68-78. PubMed ID: 43118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
    Martin GE; Williams M; Pettibone DJ; Yarbrough GG; Clineschmidt BV; Jones JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):569-76. PubMed ID: 6433000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.